Skip to main content
. 2017 Oct 17;1(11):e001396. doi: 10.3945/cdn.117.001396

TABLE 4.

Multivariable-adjusted ORs (95% CIs) of the associations between dietary patterns and high plasma biomarker pattern scores1

Dietary pattern quintile P-trend2 Per 1-SD increase in dietary pattern score
Biomarker pattern Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
Western dietary pattern
 High:low GP130-TNFR2 pattern score 121:118 119:121 112:125 116:127 131:108
 Adjusted model 1 1.05 (0.72, 1.52) 0.93 (0.64, 1.36) 1.03 (0.71, 1.50) 1.30 (0.89, 1.89) 0.24 1.05 (0.97, 1.14)
 High:low TNFR2–IL-2R pattern score 113:126 115:125 122:115 115:128 134:105
 Adjusted model 1 1.05 (0.72, 1.54) 1.07 (0.73, 1.57) 0.93 (0.63, 1.36) 1.35 (0.92, 1.99) 0.28 1.05 (0.96, 1.14)
 High:low CD14 pattern score 111:128 113:127 116:121 123:120 136:103
 Adjusted model 1 1.27 (0.85, 1.89) 1.54 (1.02, 2.31) 1.77 (1.18, 2.66) 2.04 (1.36, 3.08) 0.0002 1.19 (1.09, 1.31)
Prudent dietary pattern
  High:low GP130-TNFR2 pattern score 125:114 112:128 112:128 129:111 121:118
 Adjusted model 1 0.72 (0.50, 1.04) 0.73 (0.50, 1.06) 0.93 (0.64, 1.36) 0.80 (0.55, 1.16) 0.67 0.98 (0.90, 1.07)
  High:low TNFR2–IL-2R pattern score 141:98 115:125 107:133 122:118 114:125
 Adjusted model 1 0.65 (0.44, 0.95) 0.55 (0.37, 0.81) 0.69 (0.47, 1.01) 0.59 (0.40, 0.87) 0.03 0.91 (0.83, 0.99)
  High:low CD14 pattern score 119:120 119:121 117:123 127:113 117:122
 Adjusted model 1 0.78 (0.52, 1.17) 0.84 (0.56, 1.25) 0.98 (0.65, 1.47) 0.76 (0.51, 1.14) 0.49 0.97 (0.88, 1.06)
1

Values are n or ORs (95% CIs) unless stated otherwise. Dietary patterns were adjusted for energy intake using the residual method. Biomarker scores were classified as high (greater than or equal to the median score) compared with low (less than the median score). Median scores were −0.1215 for the GP130-TNFR2 pattern score, −0.0875 for the TNFR2–IL-2R pattern score, and −0.0170 for the CD14 pattern score. All analyses were adjusted for age at blood draw, sex, physical activity, smoking status, case-control status, BMI (in kg/m2), chronic disease comorbidity score, and regular use of aspirin, acetaminophen, other nonsteroidal anti-inflammatory drugs, or cholesterol-lowering drugs, as described in the Methods. GP130, soluble glycoprotein 130; IL-2R, soluble interleukin-2 receptor; TNFR2, soluble tumor necrosis factor receptor 2.

2

The P value for trend was the P value of the dietary pattern as a continuous variable adjusted for all covariates listed in footnote 1.